The European edition of the internationally recognised Pharma and Biotech Patent Litigation Summit will return in January 2023 for 3 days of practical discussion on the leading industry topics.
Gain the necessary practical tools to defend patent litigation challenges for your pharma and biotech product, whilst also maximising your litigation strategy to allow for successful IP protection.
Network with your industry’s leading figures and gain unique insights on the latest regulatory changes and case-law updates.
- Highlights Include:
- Discover how to tackle the challenges of litigating pharma and biotech patents with a UPC Mock Trial with our chair, Peter Meier Beck (UPC Advisory Committee)
- Understand how SPC Referral cases and the uptake of the manufacturing waiver will impact your company with Heidi Adler (Orion Corporation), James Horgan (MSD) and Robin Ellis (Reddie & Grose)
- Gain a Transatlantic knowledge of biologics patent litigation with topics including biosimilar launches, section 112, and sufficiency of disclosure with Julia Pike (Sandoz), Mike Cottler (Alvotech) and Robert Cerwinski (Gemini Law)
- Find out the best venues for litigation at the UPC and the selection of the judges with our spotlight session led by Willem Hoyng (UPC Advisory Committee Chairman)
A must-attend event for anyone working within the life sciences IP industry.
Discover who’s speaking and find out more about our sessions by viewing the agenda here: https://hubs.ly/Q01rpYqb0
Phone: +44 20 3696 2920